CLT-006

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCLT-006
Drug Alias NameSU-5416 analogs (Charlesson)combretastatin A4 analogs (Charlesson)CLT-006-168CLT-006-001SU-168 +[6] 
ClassificationSmall molecules
Mechanisms of ActionantioxidantTubulin inhibitorsVascular endothelial growth factor receptor antagonists +[4] 
TargetsTubulinVascular endothelial growth factor receptor
Therapy Area/IndicationsAngiogenesis disorderInflammationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCharlesson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCharlesson
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderInflammationDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A